CoChat

Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder

Open access
Chandley, Michelle J., Szebeni, Katalin, Szebeni, Attila, Crawford, Jessica, Stockmeier, Craig A., Turecki, Gustavo, Miguel-Hidalgo, Jose Javier, Ordway, Gregory A. · 2013 · Journal of Psychiatry and Neuroscience
Cited by 99

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background: Norepinephrine and glutamate are among several neurotransmitters implicated in the neuropathology of major depressive disorder (MDD). Glia deficits have also been demonstrated in people with MDD, and glia are critical modulators of central glutamatergic transmission. We studied glia in men with MDD in the region of the brain (locus coeruleus; LC) where noradrenergic neuronal cell bodies reside and receive glutamatergic input. Methods: The expression of 3 glutamate-related genes ( SLC1A3, SLC1A2, GLUL) concentrated in glia and a glia gene ( GFAP) were measured in postmortem tissues from men with MDD and from paired psychiatrically healthy controls. Initial gene expression analysis of RNA isolated from homogenized tissue ( n = 9–10 pairs) containing the LC were followed by detailed analysis of gene expressions in astrocytes and oligodendrocytes ( n = 6–7 pairs) laser captured from the LC region. We assessed protein changes in GFAP using immunohistochemistry and immunoblotting ( n = 7–14 pairs). Results: Astrocytes, but not oligodendrocytes, demonstrated robust reductions in the expression of SLC1A3 and SLC1A2, whereas GLUL expression was unchanged. GFAP expression was lower in astrocytes, and we confirmed reduced GFAP protein in the LC using immunostaining methods. Limitations: Reduced expression of protein products of SLC1A3 and SLC1A2 could not be confirmed because of insufficient amounts of LC tissue for these assays. Whether gene expression abnormalities were associated with only MDD and not with suicide could not be confirmed because most of the decedents who had MDD died by suicide. Conclusion: Major depressive disorder is associated with unhealthy astrocytes in the noradrenergic LC, characterized here by a reduction in astrocyte glutamate transporter expression. These findings suggest that increased glutamatergic activity in the LC occurs in men with MDD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1503/jpn.120110

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 38

  1. Kessler RC, 2003, JAMA, 289, 3095, 10.1001/jama.289.23.3095 · DOI · Paper page
  2. Ordway GA, 2007, Brain norepinephrine, 341, 10.1017/CBO9780511544156.012 · doi:10.1017/cbo9780511544156.012
  3. Ordway GA, 1999, Brain Res, 847, 71, 10.1016/S0006-8993(99)02043-0 · DOI
  4. Klimek V, 1997, J Neurosci, 17, 8451, 10.1523/JNEUROSCI.17-21-08451.1997 · DOI · Paper page
  5. Klimek V, 2003, J Psychiatr Res, 37, 387, 10.1016/S0022-3956(03)00045-1 · DOI
  6. Wong ML, 2000, Proc Natl Acad Sci U S A, 97, 325, 10.1073/pnas.97.1.325 · DOI · Paper page
  7. Hashimoto K, 2007, Biol Psychiatry, 62, 1310, 10.1016/j.biopsych.2007.03.017 · DOI · Paper page
  8. Sanacora G, 2004, Arch Gen Psychiatry, 61, 705, 10.1001/archpsyc.61.7.705 · DOI · Paper page
  9. Singewald N, 1995, Brain Res, 704, 42, 10.1016/0006-8993(95)01102-1 · DOI
  10. Karolewicz B, 2004, J Neurochem, 91, 1057, 10.1111/j.1471-4159.2004.02792.x · DOI · Paper page
  11. Karolewicz B, 2005, Neuropsychopharmacology, 30, 1557, 10.1038/sj.npp.1300781 · DOI
  12. Altshuler LL, 2010, Bipolar Disord, 12, 541, 10.1111/j.1399-5618.2010.00838.x · DOI · Paper page
  13. Bowley MP, 2002, Biol Psychiatry, 52, 404, 10.1016/S0006-3223(02)01404-X · DOI · Paper page
  14. Kelly TM, 1996, Acta Psychiatr Scand, 94, 337, 10.1111/j.1600-0447.1996.tb09869.x · DOI · Paper page
  15. Austin MC, 2002, Neuroscience, 114, 807, 10.1016/S0306-4522(02)00289-0 · DOI
  16. Ordway GA, 2012, Int J Neuropsychopharmacol, 15, 855, 10.1017/S1461145711001350 · DOI
  17. Ordway GA, 2009, J Neurosci Res, 87, 2430, 10.1002/jnr.22078 · DOI
  18. Xiang L, 2008, Brain Res, 1207, 214, 10.1016/j.brainres.2008.02.009 · DOI
  19. Pitt D, 2003, Neurology, 61, 1113, 10.1212/01.WNL.0000090564.88719.37 · DOI · Paper page
  20. Fleige S, 2006, Biotechnol Lett, 28, 1601, 10.1007/s10529-006-9127-2 · DOI · Paper page
  21. Jen JC, 2005, Neurology, 65, 529, 10.1212/01.WNL.0000172638.58172.5a · DOI · Paper page
  22. Rao JS, 2012, J Affect Disord, 136, 63, 10.1016/j.jad.2011.08.017 · DOI · Paper page
  23. Bechtholt-Gompf AJ, 2010, Neuropsychopharmacology, 35, 2049, 10.1038/npp.2010.74 · DOI · Paper page
  24. Lee SG, 2008, J Biol Chem, 283, 13116, 10.1074/jbc.M707697200 · DOI · Paper page
  25. Mineur YS, 2007, Biol Psychiatry, 61, 250, 10.1016/j.biopsych.2006.04.037 · DOI
  26. Fumagalli E, 2008, Eur J Pharmacol, 578, 171, 10.1016/j.ejphar.2007.10.023 · DOI · Paper page
  27. Gittins RA, 2011, J Affect Disord, 133, 328, 10.1016/j.jad.2011.03.042 · DOI
  28. Davis S, 2002, J Neurol Neurosurg Psychiatry, 73, 556, 10.1136/jnnp.73.5.556 · DOI · Paper page
  29. Si X, 2004, Neuropsychopharmacology, 29, 2088, 10.1038/sj.npp.1300525 · DOI · Paper page
  30. Fatemi SH, 2004, Schizophr Res, 69, 317, 10.1016/j.schres.2003.08.014 · DOI · Paper page
  31. Gosselin RD, 2009, Neuroscience, 159, 915, 10.1016/j.neuroscience.2008.10.018 · DOI · Paper page
  32. Hösli L, 1982, Neuroscience, 7, 2867, 10.1016/0306-4522(82)90109-9 · DOI
  33. Fahrig T, 1993, Glia, 7, 212, 10.1002/glia.440070304 · DOI
  34. Hansson E, 1992, Brain Res Bull, 29, 297, 10.1016/0361-9230(92)90060-B · DOI
  35. Aston-Jones G, 1986, Science, 234, 734, 10.1126/science.3775363 · DOI · Paper page
  36. Valentino RJ, 2001, Neuroscience, 106, 375, 10.1016/S0306-4522(01)00279-2 · DOI
  37. Perea G, 2010, Brain Res Rev, 63, 93, 10.1016/j.brainresrev.2009.10.005 · DOI · Paper page
  38. Banasr M, 2008, Biol Psychiatry, 64, 863, 10.1016/j.biopsych.2008.06.008 · DOI · Paper page

Cited by

Metadata

Authors
Chandley, M. J., Szebeni, K., Szebeni, A., Crawford, J., Stockmeier, C. A., Turecki, G., Miguel-Hidalgo, J. J., & Ordway, G. A.
Venue
Journal of Psychiatry and Neuroscience
Published
2013-07
Volume
38
Issue
4
Pages
276-284
ISSN
  • 1180-4882 (ISSN-L)
  • 1488-2434
OpenAlex
W1965556606
Cited by
99
References
17
FWCI
5.86
Type
journal article
Language
en
Open access
green
Licence
www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.